Carolin Roth is based in London and is an anchor for "Capital Connection". Carolin also covers the Swiss market for CNBC. Fluent in both German and English, she has been with CNBC since 2007, reporting on air since 2009. She has also hosted European Closing Bell and co-anchored Squawk Box (Europe) from CNBC's London studios. Carolin also contributes to CNBC programming in the US.
Carolin has covered key events for CNBC including WEF, European debt crisis live out of Greece, Italy, Spain,Hungary and Cyprus, the German election campaign and the Geneva motor show.
Carolin gained experience in the financial sector in Germany and the US before completing her Masters degree in Banking and Finance from the University of Zurich.
Follow Carolin on Twitter @CarolinCNBC.
ArtBasel, to many the most prestigious modern- and contemporary art fair, opened its doors on June 15 for the 42nd time, hot on the heels of the Venice Biennale last week.
Swiss-based commodity trader Glencore is set to unveil the pricing of its mammoth $12 billion dual IPO in London and Hong Kong later this week, and in what will be be the biggest IPO of the year and the largest in the UK to date, its shares are expected to start regular trading on the London exchange on May 24 and in Hong Kong just one day later.
Swiss policymakers will hold an emergency meeting with key business groups, labor unions and representatives from the machinery, tourism and pharmaceutical sectors to discuss the Swiss franc's damaging impact on the Alpine country's economy Friday.
Swiss pharmaceuticals giant Roche said it would appeal a decision by the US Food and Drug Administration to remove the approval for the drug’s indication for metastatic breast cancer, but analysts doubt the appeal would be successful.